2-溴-α-麦角隐亭甲磺酸盐

Name: 2-溴-α-麦角隐亭甲磺酸盐
Brand: 济南圣和化工有限公司

CAS 22260-51-1C33H44BrN5O8SMW 750.7

本页收录 2-溴-α-麦角隐亭甲磺酸盐，CAS 登记号为 22260-51-1，分子式 C33H44BrN5O8S，分子量 750.7，归类于有机化学品。作为主营产品之一，济南圣和化工有限公司可提供从公斤级到吨级的稳定供货，随货附 COA 与质检资料。

产品概览

CAS号	22260-51-1
分子式	C33H44BrN5O8S
分子量	750.7
纯度	按批次COA提供(不公开发布)
包装	按订单/批次确认(不公开发布)
应用领域	有机化学品
类别	有机化学品

应用领域

有机化学品

2-溴-α-麦角隐亭甲磺酸盐主要应用于有机化学品。具体使用工况下的添加量与规格要求，欢迎与技术团队沟通确认。

包装与储存

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

运输常规化工运输

样品可协商提供

交期现货/按订单安排

采购提示：本产品按按订单/批次确认(不公开发布)起订发货，收到货物后请先核对包装完好性再行入库。储存条件为阴凉干燥、密封保存；如需 MSDS 或运输说明，可在询价时一并索取。

质量与文件

每批产品随货提供 COA（分析证书）；可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

作为化工原料供应服务商，济南圣和化工有限公司长期服务于化工贸易、食品添加、医药中间体、日化原料等行业的采购需求。除 2-溴-α-麦角隐亭甲磺酸盐外，您还可以在站内按 CAS 号或产品分类检索更多品类，获取规格与报价。

常见问题

2-溴-α-麦角隐亭甲磺酸盐的 CAS 号是多少？

2-溴-α-麦角隐亭甲磺酸盐的 CAS 号为 22260-51-1。

该产品的纯度和包装规格是什么？

常规纯度规格为按批次COA提供(不公开发布)，包装为按订单/批次确认(不公开发布)，随货提供 COA。

2-溴-α-麦角隐亭甲磺酸盐有什么用途？

主要应用于有机化学品。

如何购买或获取报价？

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系，注明产品名称、CAS 号与需求数量，一个工作日内回复报价。供应商：济南圣和化工有限公司。

PubChem 公开数据

Description

2-bromo-alpha-ergocryptine methane-sulfonate · CAS 22260-51-1 · C33H44BrN5O8S. UNII FFP983J3OD.

Identification

CAS Registry Number	22260-51-1
PubChem CID	31100
Molecular formula	C33H44BrN5O8S
IUPAC name	(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
UNII (FDA)	FFP983J3OD

Computed Descriptors

Molecular Weight	750.7
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	5
Exact Mass	749.20940
Monoisotopic Mass	749.20940
Topological Polar Surface Area	181
Heavy Atom Count	48
Formal Charge	0
Complexity	1320

Physical description & handling notes

244.4 Å² [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

GHS Hazard Classification

Reported hazard statements	H302 (45.5%), H332 (36.4%), H361 (45.5%), H362 (18.2%), H400 (45.5%), H410 (72.7%)

H302 (45.5%): Harmful if swallowed [Warning Acute toxicity, oral]

H332 (36.4%): Harmful if inhaled [Warning Acute toxicity, inhalation]

Documented Uses

Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.
Drugs that bind to and activate dopamine receptors.
Ergot Derivative [EPC]; Ergolines [CS]
Completely metabolized by the liver, primarily by hydrolysis of the amide bond to produce lysergic acid and a peptide fragment, both inactive and non-toxic. Bromocriptine is metabolized by cytochrome P450 3A4 and excreted primarily in the feces via biliary secretion. Route of Elimination: Parent drug and metabolites are almost completely excreted via the liver, and only 6% eliminated via the kidney. Half Life: 2-8 hours

Synonyms

BROMOCRIPTINE MESYLATE; 22260-51-1; Bromocriptine mesilate; Pravidel; Cycloset; Bagren; Bromocriptine methanesulfonate; CB-154 mesylate; Cb-154 mesilate; 2-Bromoergocryptine Mesylate; 2-Bromo-alpha-ergocryptine mesylate; DTXSID6020197; FFP983J3OD; NSC-755915; DTXCID00197; CHEBI:3182

Frequently Asked Questions

What are the CAS number and molecular formula of 2-bromo-alpha-ergocryptine methane-sulfonate?

CAS 22260-51-1; molecular formula C33H44BrN5O8S; molecular weight — g/mol.

What other names is 2-bromo-alpha-ergocryptine methane-sulfonate known by?

BROMOCRIPTINE MESYLATE, 22260-51-1, Bromocriptine mesilate, Pravidel, Cycloset, Bagren.

Is 2-bromo-alpha-ergocryptine methane-sulfonate classified as hazardous?

Hazard statements reported: H302, H332, H361, H362, H400.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.